immatics biotechnologies GmbH (NASDAQ:IMTXW – Get Rating)'s stock price traded up 3.5% during trading on Monday . The company traded as high as $1.46 and last traded at $1.46. 102 shares were traded during mid-day trading, a decline of 99% from the average session volume of 10,923 shares. The stock had previously closed at $1.41.

immatics biotechnologies Price Performance

The stock's 50 day moving average is $1.93.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Virtu Financial LLC bought a new stake in immatics biotechnologies in the 4th quarter valued at about $28,000. Jefferies Financial Group Inc. bought a new stake in shares of immatics biotechnologies in the fourth quarter valued at approximately $80,000. Alyeska Investment Group L.P. purchased a new stake in shares of immatics biotechnologies during the 4th quarter valued at approximately $529,000. Finally, Aristeia Capital LLC boosted its holdings in immatics biotechnologies by 3,293.6% in the 4th quarter. Aristeia Capital LLC now owns 754,590 shares of the company's stock worth $1,856,000 after buying an additional 732,354 shares during the period.

See Also

• Get a free copy of the StockNews.com research report on immatics biotechnologies (IMTXW)
• This Is Why Penny Stock GreenPower Motor Company Is A Win
• Comcast Sum of All Parts is Producing a Cumulative Effect
• The Greenbrier Companies: All Aboard For High-Yield In 2023
• Coty Stock is on the Comeback Trail
• Splunk Stock is an AI-Powered Enterprise SEIM Play

Receive News & Ratings for immatics biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for immatics biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.